Sign in >>

News item: Merck, QIAGEN to collaborate to increase access to HPV vaccination and HPV DNA testing in developing countries (News-Medical-Net)

Merck & Co., Inc. and QIAGEN N.V. today announced their intent to collaborate on a new program to increase access to HPV vaccination and HPV DNA testing in some of the most resource-poor areas of the world.

Posted over 2 years ago

Continue reading...

Back to news index

Related sites from Google



Send feedback about this page
Email a link to this page

This topic elsewhere

Loading...
Loading...